Thomas Dietz

Dr. Thomas J.
Dietz is a Lead Independent Director at Cypherpunk Technologies, Inc., a Managing Member at Codpiece Properties LLC, a Managing Member at Codfish Investments LLC, a Chairman & Chief Executive Officer at Waypoint Holdings LLC and a Chairman at Galleon Pharmaceuticals, Inc. He is on the Board of Directors at Nutcracker Therapeutics, Inc., Cypherpunk Technologies, Inc., AgBiome INC, Glialogix, Inc. and California Pacific Medical Center.
Dr. Dietz was previously employed as a Co-Founder by Firebrand River Capital LLC, an Independent Non-Executive Chairman by Eiger BioPharmaceuticals, Inc., an Independent Director by Eiger BioPharmaceuticals, Inc. /Old/, an Independent Director by Paratek Pharmaceuticals, Inc., an Independent Director by Pivot Acquisition, Inc., a Head-Investment Banking by Wedbush Securities, Inc., a Chief Executive Officer & Director by Pacific Growth Equities, Inc., a Trustee-West Bay Region by Sutter Health, a Member-Research Faculty by The University of California, San Francisco, and a Research Faculty Member by VA Medical Center (District of Columbia).
He also served on the board at Virobay, Inc. He received his undergraduate degree from State University of New York at Albany and a doctorate degree from Washington University in St. Louis.